中文名称:
内分泌
期刊缩写:
ENDOCRINE
影响因子:
3
ISSN:
print: 1355-008X
on-line: 1559-0100
研究领域:
ENDOCRINOLOGY & METABOLISM
创刊年份:
1995年
h-index:
74
自引率:
5.40%
Gold OA文章占比:
24.97%
原创研究文献占比:
81.99%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
6.50.8440.941
学科
排名
百分位
大类:Medicine
小类:Endocrinology, Diabetes and Metabolism
79 / 244
67%
大类:Biochemistry, Genetics and Molecular Biology
小类:Endocrinology
48 / 128
62%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
3区 医学
3区 内分泌学与代谢 ENDOCRINOLOGY & METABOLISM
WOS期刊分区
学科分类
Q2ENDOCRINOLOGY & METABOLISM
历年影响因子
2017年3.2790
2018年3.1310
2019年3.1790
2020年3.2960
2021年3.6330
2022年3.7000
2023年3.0000
历年发表
2012年274
2013年271
2014年377
2015年319
2016年377
2017年280
2018年332
2019年332
2020年386
2021年392
2022年295
投稿信息
出版周期:
12 issues per year
出版语言:
English
出版国家(地区):
UNITED STATES
审稿时长:
1.5 months
出版商:
Springer US
编辑部地址:
ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United States, NY, 10004

Endocrine - 最新文献

SGLT2 inhibitors may reduce non-small cell lung cancer and not increase various neoplasms including several skin cancers.

Pub Date : 2024-12-01 DOI: 10.1007/s12020-024-03914-0 Yu Xiao, Wanying Yang, Muyang Wang

Clarification on the role of thyroid scintigraphy in the era of TIRADS: a response to Trimboli et al. (2024).

Pub Date : 2024-12-01 DOI: 10.1007/s12020-024-03913-1 Sokratis El Mantani Ordoulidis, Maria Siampanopoulou

Factors affecting growth hormone treatment in short stature children born small for gestational age in China: a single-centre, real-world study.

Pub Date : 2024-12-01 DOI: 10.1007/s12020-024-04009-6 Li Xi, Ruoqian Cheng, Yingkai He, Xiaojing Li, Jinwen Ni, Jing Wu, Zhenran Xu, Feihong Luo
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信